銳迪國際科技有限公司 Company Information
Company Name:
RD International Technology Co., Limited
Tel:
-
Email:
market@ubiochem.com
Nationality:
China
WebSite:
www.ruidiresearch.com
Product List:
9180
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
Product List
Vandetanib
443913-73-3
Motesanib
453562-69-1
Nintedanib Ethanesulfonate Salt
656247-18-6
Masitinib mesylate
1048007-93-7
Dasatinib hydrochloride
854001-07-3
Multi-kinase inhibitor 1
778274-97-8
Mirk-IN-1
1386979-55-0
Orelabrutinib
1655504-04-3
SU4312
5812-07-7
Pralsetinib
2097132-94-8
Acrizanib
1229453-99-9
Lanraplenib succinate
1800047-00-0
UNC2025 hydrochloride
2070015-17-5
ENMD-2076
934353-76-1
Ibrutinib-biotin
1599432-18-4
JH-VIII-157-02
1639422-97-1
SRI 31215 TFA
1832686-44-8
Tyrphostin AG1433
168835-90-3
Sunitinib Malate
341031-54-7
Cabozantinib S-malate
1140909-48-3
Ningetinib Tosylate
1394820-77-9
BMS-935177
1231889-53-4
JNJ-38877618
943540-74-7
TAS-115 mesylate
1688673-09-7
AZ-Dyrk1B-33
1679330-37-0
Jaspamycin
22242-96-2
FGFR1/DDR2 inhibitor 1
2308497-58-5
SU14813 maleate
849643-15-8
Vorolanib
1013920-15-4
tBID
1639895-85-4
AZD7507
1041852-85-0
UNC2541
1612782-86-1
Y15
4506-66-5
PF-573228
869288-64-2
Pazopanib Hydrochloride
635702-64-6
SU16f
251356-45-3
R406
841290-81-1
Toceranib phosphate
874819-74-6
TG 100572 Hydrochloride
867331-64-4
Brigatinib
1197953-54-0
Btk inhibitor 2
1558036-85-3
ARQ 531
2095393-15-8
Rp-cAMPS sodium salt
142439-94-9
Vecabrutinib
1510829-06-7
Remibrutinib
1787294-07-8
BT-13
924537-98-4
cFMS Receptor Inhibitor II
959860-85-6
Bozitinib
1440964-89-5
WRG-28
1913291-02-7
Lyn-IN-1
887650-05-7
Lck inhibitor 2
944795-06-6
INDY
1169755-45-6
SKLB4771
1370256-78-2
Gilteritinib hemifumarate
1254053-84-3
(±)-Zanubrutinib
1633350-06-7
MAZ51
163655-37-6
RU-301
1110873-99-8
PDGFRα kinase inhibitor 1
2209053-93-8
SPP-86
1357349-91-7
AG 1295
71897-07-9
Nilotinib
641571-10-0
BMS-509744
439575-02-7
PF-06465469
1407966-77-1
CHMFL-BMX-078
1808288-51-8
TAK-659 hydrochloride
1952251-28-3
Ensartinib hydrochloride
2137030-98-7
PRN1008
1575596-29-0
Bosutinib
380843-75-4
Rp-cAMPS triethylammonium salt
151837-09-1
A-770041
869748-10-7
Lck Inhibitor
847950-09-8
Tyrosine kinase inhibitor
1021950-26-4
Ibrutinib D5
1553977-17-5
Tirbanibulin Mesylate
1080645-95-9
PRN694
1575818-46-0
TL02-59
1315330-17-6
FN-1501
1429515-59-2
AZD3229 Tosylate
2248003-71-4
CLK-IN-T3
2109805-56-1
CSF1R-IN-1
2095849-04-8
TAM-IN-2
2135642-56-5
BPR1K871
2443767-35-7
AGL-2263
638213-98-6
Syk-IN-1
1491150-77-6
Tivozanib
475108-18-0
DPH
484049-04-9
Dovitinib lactate
692737-80-7
KB SRC 4
1380088-03-8
Osteogenic Growth Peptide (10-14)
105250-85-9
trans-Pralsetinib
2097132-93-7
Hck-IN-1
1473404-51-1
Pivanex
122110-53-6
Petunidin chloride
1429-30-7
TIE-2/VEGFR-2 kinase-IN-1
453590-24-4
PF-04217903 methanesulfonate
956906-93-7
Tirbanibulin dihydrochloride
1038395-65-1
3-Hydroxy Midostaurin
179237-49-1
Conteltinib
1384860-29-0
PD173074
219580-11-7
Sunitinib
557795-19-4
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
Copyright 2007© ChemicalBook. All rights reserved.